Indian Drug Makers See More Bulk Products From China
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers complain Chinese companies plan to flood the Indian market with cheaper pharmaceuticals and medical devices, in some cases at half-price. Chinese firms have been blamed in India already for flooding the market with cheaper bulk drugs, but now they are seen entering other parts of the bulk supply market. The products headed for India range from traditional medicines to pharmaceuticals to medical instruments. Major producers of branded drugs in India are not expected to be hit as hard by the new competition as small-scale businesses. (Click here for more
You may also be interested in...
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.